Adjusting Imports of Pharmaceuticals and Pharmaceutical Ingredients Into the United States
ProclamationTariff raisedSigned 04/02Federal Register 04/09Open the original
Summary
President Trump directs actions under section 232 on imports of pharmaceuticals and pharmaceutical ingredients. Patented pharmaceuticals and associated ingredients face a 100% ad valorem duty, while products from companies with approved plans to onshore production face a 20% duty.
By industry
- Healthcare & Drug Pricing1 trading day−0.3%p15 stocks5 trading days−1.9%p15 stocks20 trading days−7.9%p15 stocks
“Adjusting Imports of Pharmaceuticals and Pharmaceutical Ingredients Into the United States”
- Tariffs & Reshoring1 trading day−0.8%p15 stocks5 trading days+1.6%p15 stocks20 trading days+0.3%p15 stocks
“I have determined that it is necessary and appropriate to impose a 100 percent ad valorem duty rate”
Day by day after the announcement
| Day | Healthcare & Drug Pricing stocks | S&P 500 |
|---|---|---|
| 26/04/01 | 0.0% | 0.0% |
| 26/04/02 | −0.2% | +0.1% |
| 26/04/06 | +1.0% | +0.6% |
| 26/04/07 | −0.0% | +2.9% |
| 26/04/08 | +1.6% | +3.0% |
| 26/04/09 | +1.8% | +3.7% |
| 26/04/10 | +0.6% | +3.8% |
| 26/04/13 | +0.6% | +4.8% |
| 26/04/14 | +0.7% | +6.0% |
| 26/04/15 | −0.3% | +6.8% |
| 26/04/16 | +0.3% | +7.1% |
| 26/04/17 | +1.4% | +8.4% |
| 26/04/20 | +0.4% | +8.3% |
| 26/04/21 | −0.1% | +7.9% |
| 26/04/22 | −0.6% | +8.4% |
| 26/04/23 | +0.7% | +8.3% |
| 26/04/24 | −0.5% | +8.9% |
| 26/04/27 | −0.6% | +9.3% |
| 26/04/28 | +0.5% | +8.7% |
| 26/04/29 | +1.1% | +8.8% |
| 26/04/30 | +2.0% | +9.9% |
Korean stocks in these industries
- Samsung Biologics 207940
- Celltrion 068270
- SK Biopharmaceuticals 326030
- Hyundai Steel 004020
- POSCO Holdings 005490
- SeAH Steel Holdings 003030
Trades in these industries around the announcement
Members' and insiders' trades in the industries' stocks, 30 days before to 30 days after.
- Alan Armstrong
BuyUnitedhealth Group
BuyUnitedhealth Group
UNH
$15K–$50K
Self
$15K–$50K
Reported 07/21
Traded 03/27
- Alan Armstrong
Full saleAmgen
Full saleAmgen
AMGN
$15K–$50K
Self
$15K–$50K
Reported 07/21
Traded 03/27
- Alan Armstrong
Full salePfizer
Full salePfizer
PFE
$50K–$100K
Self
$50K–$100K
Reported 07/21
Traded 03/24
- Lilly Endowment
SellELI Lilly
SellELI Lilly
LLY
$13.6M
13,620 sh
$13.6M
Filed 05/07
Traded 05/06
- Alan Armstrong
BuyAbbVie
BuyAbbVie
ABBV
$15K–$50K
Self
$15K–$50K
Reported 07/21
Traded 03/27
- Alan Armstrong
BuyJohnson & Johnson
BuyJohnson & Johnson
JNJ
$15K–$50K
Self
$15K–$50K
Reported 07/21
Traded 03/27
- Alan Armstrong
Full saleMerck
Full saleMerck
MRK
$15K–$50K
Self
$15K–$50K
Reported 07/21
Traded 03/27
- Keith Harvey
SellKaiser Aluminum
SellKaiser Aluminum
KALU
$8.2M
47,001 sh
$8.2M
Filed 04/29
Traded 04/27
- Alan Armstrong
BuyMcKesson
BuyMcKesson
MCK
$1K–$15K
Self
$1K–$15K
Reported 07/21
Traded 03/27
- Alan Armstrong
BuyElevance Health
BuyElevance Health
ELV
$1K–$15K
Self
$1K–$15K
Reported 07/21
Traded 03/27
- Alan Armstrong
BuyJohnson & Johnson
BuyJohnson & Johnson
JNJ
$1K–$15K
Self
$1K–$15K
Reported 07/21
Traded 03/30
- Alan Armstrong
BuyGilead Sciences
BuyGilead Sciences
GILD
$1K–$15K
Self
$1K–$15K
Reported 07/21
Traded 03/27
- Alan Armstrong
Full saleELI Lilly
Full saleELI Lilly
LLY
$1K–$15K
Self
$1K–$15K
Reported 07/21
Traded 03/27
- Patrick Hugh Conway
SellUnitedhealth Group
SellUnitedhealth Group
UNH
$284K
800 sh
$284K
Filed 04/27
Traded 04/23
- Lilly Endowment
SellELI Lilly
SellELI Lilly
LLY
$2.2M
2,208 sh
$2.2M
Filed 05/07
Traded 05/06
- David V. Elkins
SellBristol Myers Squibb
SellBristol Myers Squibb
BMY
$1.6M
25,519 sh
$1.6M
Filed 04/02
Traded 04/01
- Daniel Patrick O'Day
Sell10b5-1 planGilead Sciences
Sell10b5-1 planGilead Sciences
GILD
$1.4M
10,000 sh
$1.4M
Filed 03/30
Traded 03/27
- Leon J. Topalian
SellNucor
SellNucor
NUE
$1M
6,454 sh
$1M
Filed 03/25
Traded 03/23
- Daniel Patrick O'Day
Sell10b5-1 planGilead Sciences
Sell10b5-1 planGilead Sciences
GILD
$895.1K
6,950 sh
$895.1K
Filed 04/29
Traded 04/28
- Neal E. West
SellKaiser Aluminum
SellKaiser Aluminum
KALU
$866.5K
5,000 sh
$866.5K
Filed 04/29
Traded 04/28